Aktis Oncology Inc (AKTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKTS | CRON | EVO | ||
| Company | Aktis Oncology Inc | Cronos Group Inc | Evotec Se | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.04 | 2.51 | 2.58 | ||
| High | 18.63 | 2.56 | 2.58 | ||
| Low | 17.56 | 2.51 | 2.56 | ||
| Latest | 17.70 | 2.52 | 2.56 | ||
| Change | -0.19 | +0.01 | +0.06 | ||
| % Change | -1.06% | +0.40% | +2.20% | ||
| Volume | 64,898 | 247,872 | 32,434 | ||
| 20-Day Average Volume | 549,319 | 996,807 | 128,554 | ||
| Previous Close | 17.89 | 2.51 | 2.50 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 18.37 | 2.52 | 2.54 | ||
| 20-Day Raw Stochastic | 42.40% | 52.63% | 29.23% | ||
| 20-Day Relative Strength | 44.97 | 48.10 | 41.55 | ||
| Weighted Alpha | N/A | +22.59 | -18.91 | ||
| Today's Opinion | N/A | 16% Sell | 88% Sell | ||
| Previous Opinion | N/A | 32% Sell | 100% Sell | ||
| Last Month's Opinion | N/A | 32% Buy | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.31% since 03/25/26 | -3.44% since 03/25/26 | +1.59% since 03/25/26 | ||
| Low | 14.72 on 03/30/26 | 2.41 on 03/30/26 | 2.34 on 03/30/26 | ||
| High | 19.36 on 03/31/26 | 2.64 on 03/26/26 | 2.58 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | -12.32% since 02/27/26 | -5.24% since 02/27/26 | -24.71% since 02/27/26 | ||
| Low | 14.72 on 03/30/26 | 2.38 on 03/20/26 | 2.31 on 03/13/26 | ||
| High | 21.63 on 03/05/26 | 2.68 on 03/04/26 | 3.33 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | N/A since 01/09/26 | -3.80% since 12/31/25 | -16.88% since 12/31/25 | ||
| Low | 14.72 on 03/30/26 | 2.38 on 03/20/26 | 2.31 on 03/13/26 | ||
| High | 29.16 on 01/09/26 | 2.83 on 01/23/26 | 3.87 on 01/13/26 | ||
| 6-Month | |||||
| %Chg | N/A since 01/09/26 | -4.89% since 10/01/25 | -31.91% since 10/01/25 | ||
| Low | 14.72 on 03/30/26 | 2.28 on 11/21/25 | 2.31 on 03/13/26 | ||
| High | 29.16 on 01/09/26 | 3.43 on 12/15/25 | 4.27 on 10/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 906,110 | 954,192 | 888,730 | ||
| Shares Outstanding, K | 50,649 | 380,156 | 355,492 | ||
| Annual Sales | 27,380,000 | 146,590,000 | 862,400,000 | ||
| Annual Net Income | -167,950,000 | -9,450,000 | -212,180,000 | ||
| Last Quarter Sales | 1,870,000 | 44,530,000 | 191,570,000 | ||
| Last Quarter Net Income | -15,138,000 | -1,820,000 | -50,360,000 | ||
| 60-Month Beta | N/A | 0.78 | 1.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.00 on 02/26/26 | N/A on 11/05/25 | ||
| Latest Earnings Date | 02/11/25 | 05/14/26 | 11/05/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||